Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +1-00000000000 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| GSK3532795；BMS-955176 | C42H62N2O4S | 1392312-45-6 | Details |
| GRL0617 | C20H20N2O | 1093070-16-6 | Details |
| GOAT-IN-1 | C18H13ClF3NO3S | 1452473-54-9 | Details |
| GNF4877 | C25H27FN6O4 | 2041073-22-5 | Details |
| Lidocaine hydrochloride | C14H23ClN2O | 73-78-9 | Details |
| Gosogliptin；PF-00734200;PF-734200 | C17H24F2N6O | 869490-23-3 | Details |
| GSK2245035 | C20H34N6O2 | 1207629-49-9 | Details |
| GSK 4027 | C17H21BrN4O | 2079896-25-4 | Details |
| GSK598809 | C22H23F4N5OS | 863680-45-9 | Details |
| GR 103691 | C30H35N3O3 | 162408-66-4 | Details |
| Ganfeborole HCl | C10H14BCl2NO4 | 2131798-13-3 | Details |
| GSK4028 | C17H21BrN4O | 2079886-19-2 | Details |
| GSK3004774 | C32H40N4O3 | 2138814-32-9 | Details |
| Fiboflapon sodium；GSK2190915 sodium salt;AM-803 sodium | C38H44N3NaO4S | 1196070-26-4 | Details |
| Fiboflapon；AM-803;GSK2190915 | C38H43N3O4S | 936350-00-4 | Details |
| GSK2983559 free acid | C21H23N4O7PS2 | 1579965-12-0 | Details |
| Fenofibrate | C20H21ClO4 | 49562-28-9 | Details |
| GPR84 antagonist 8 | C23H23N3O5 | 1445846-30-9 | Details |
| GSK256066 Trifluoroacetate；GSK 256066 Trifluoroacetate;GSK256066 (2,2,2-trifluoroacetic acid) | C29H27F3N4O7S | 1415560-64-3 | Details |
| GlyRS-IN-1 | C12H17N7O7S | 112921-11-6 | Details |
| GlyT1 Inhibitor 1 | C22H21N5O2 | 1820934-93-7 | Details |
| GNA002 | C42H55NO8 | 1385035-79-9 | Details |
| GNE-616 | C24H23F4N5O3S | 2349371-81-7 | Details |
| GNE-8505 | C21H24F3N5O | 1620573-48-9 | Details |
| GSK-3 inhibitor 1 | C22H17ClFN5O2 | 603272-51-1 | Details |
| GNF179 (Metabolite)；GNF179 Metabolite | C14H16FN3 | 1310455-86-7 | Details |
| GNE 220 | C25H26N8 | 1199590-75-4 | Details |
| GSK1059865 | C20H23BrFN3O2 | 1191044-58-2 | Details |
| GSK 525768A | C22H22ClN5O2 | 1260530-25-3 | Details |
| GSK 366 | C17H16ClN3O4 | 1953157-39-5 | Details |
| GSK-3484862 | C19H19N5OS | 2170136-65-7 | Details |
| Chlorhexidine dihydrochloride；Chlorhexidine 2HCl;NSC-185;Chlorhexidine hydrochloride | C22H32Cl4N10 | 3697-42-5 | Details |
| Glyoxalase I inhibitor | C21H30BrClN4O8S | 221174-33-0 | Details |
| GSK2807 Trifluoroacetate | C21H33F3N8O7 | 2245255-66-5 | Details |
| GPR40 Activator 2 | C28H29NO6S2 | 1312787-30-6 | Details |
| GPR40 Activator 1 | C31H31NO3S | 1309435-60-6 | Details |
| GPR35 agonist 1 | C10H4BrN5O5 | 2079880-92-3 | Details |
| GSK1521498 | C24H23F2N4O4P | 1426543-84-1 | Details |
| GSK1521498 free base | C24H20F2N4 | 1007573-18-3 | Details |
| GSK1521498 free base (hydrochloride) | C24H21ClF2N4 | 1007578-24-6 | Details |
| Diminazene Aceturate | C22H29N9O6 | 908-54-3 | Details |
| Lidocaine Hydrochloride hydrate | C14H25ClN2O2 | 6108-05-0 | Details |
| Golotimod | C16H19N3O5 | 229305-39-9 | Details |
| GPI-1046 | C20H28N2O4 | 186452-09-5 | Details |
| Epelsiban；GSK 557296 | C30H38N4O4 | 872599-83-2 | Details |
| Gusperimus trihydrochloride；BMS181173;NKT-01;Spanidin | C17H37N7O3.3ClH | 85468-01-5 | Details |
| GW806742X | C25H22F3N7O4S | 579515-63-2 | Details |
| GYKI 52466 dihydrochloride | C17H16ClN3O2 | 2319722-40-0 | Details |
| GW 766994；GW 994 | C21H24Cl2N4O3 | 408303-43-5 | Details |
| GW768505A free base | C27H19F4N5O3 | 501693-25-0 | Details |
| Albendazole | C12H15N3O2S | 54965-21-8 | Details |
| GSK-5498A | C18H11F6N3O | 1253186-49-0 | Details |
| Molibresib besylate；GSK 525762C;I-BET 762 besylate | C28H28ClN5O5S | 1895049-20-3 | Details |
| GSK2239633A | C24H25ClN4O5S2 | 1240516-71-5 | Details |
| Menbutone | C15H14O4 | 3562-99-0 | Details |
| GPR4 antagonist 1 | C27H37N5 | 1197879-16-5 | Details |
| Nifedipine；Procardia XL;Procardia;BAY-a-1040;Adalat | C17H18N2O6 | 21829-25-4 | Details |
| Lenacapavir | C39H32ClF10N7O5S2 | 2189684-44-2 | Details |
| GSK682753A | C23H21Cl3N2O3 | 1334294-76-6 | Details |
| GSK-843 | C19H15N5S2 | 1601496-05-2 | Details |
| GPR40 agonist 1 | C27H30FN3O4 | 1853982-41-8 | Details |
| GW274150 phosphate | C8H20N3O6PS | 438542-15-5 | Details |
| GV-58 | C18H26N6OS | 1402821-41-3 | Details |
| GSK2850163 | C24H29Cl2N3O | 2121989-91-9 | Details |
| Gum arabic；Arabic gum | N/A | 9000-01-5 | Details |
| H-89 | C20H20BrN3O2S | 127243-85-0 | Details |
| GZD856 | C29H27F3N6O | 1257628-64-0 | Details |
| Guancydine；Guancidine | C7H14N4 | 1113-10-6 | Details |
| Camicinal；GSK962040 | C25H33FN4O | 923565-21-3 | Details |
| Camicinal hydrochloride；GSK962040 hydrochloride | C25H34ClFN4O | 923565-22-4 | Details |
| Roxithromycin | C41H76N2O15 | 80214-83-1 | Details |
| Guaiapate | C18H29NO4 | 852-42-6 | Details |
| GSK3368715 dihydrochloride | C20H39ClN4O2 | 1628925-77-8 | Details |
| Guanosine-5'-triphosphate disodium salt | C10H17N5NaO14P3 | 56001-37-7 | Details |
| GSK840；GSK'840 | C21H23N3O3 | 2361146-30-5 | Details |
| GPR40/FFAR1 modulator 1 | C21H19N5O3 | 874755-26-7 | Details |
| GSK2593074A | C27H23N5OS | 1337531-06-2 | Details |
| GPR120 modulator 2 | C20H18ClNO3S | 1050506-87-0 | Details |
| GSK2945 | C20H18Cl2N2O2S | 1438071-12-5 | Details |
| GSK-3β inhibitor 2 | C14H14N4O3S | 1702428-31-6 | Details |
| GNF362 | C22H21F3N6 | 1003019-41-7 | Details |
| GNE-0439 | C21H31NO3 | 1241902-40-8 | Details |
| NE 52-QQ57 | C24H28N6O | 1401728-56-0 | Details |
| GSK-3β inhibitor 1 | C14H10N2O | 187325-53-7 | Details |
| GNF-6231 | C24H25FN6O2 | 1243245-18-2 | Details |
| GPR120 modulator 1 | C19H16ClNO4S | 1050506-75-6 | Details |
| GSK726701A | C24H22FNO5 | 945721-87-9 | Details |
| GSTO1-IN-1 | C10H12Cl2N2O3S | 568544-03-6 | Details |
| GSTO-IN-2 | C33H52N2O9 | 1202710-57-3 | Details |
| Guanfu base H；Atisinium chloride | C22H34ClNO2 | 4758-99-0 | Details |
| GW274150 | C8H17N3O2S | 210354-22-6 | Details |
| GSK3368715；EPZ019997 | C20H38N4O2 | 1629013-22-4 | Details |
| GSK-J2 | C22H23N5O2 | 1394854-52-4 | Details |
| GSK205 | C24H25BrN4S | 1263068-83-2 | Details |
| GSK-2793660 | C20H27N3O3 | 1613458-70-0 | Details |
| GSK2973980A | C25H19F5N4O4 | 2219321-25-0 | Details |
| GPR120 Agonist 1 | C20H12ClF6NO3S | 1628448-77-0 | Details |
| Guanfu base I；Acorine | C22H29NO5 | 110225-59-7 | Details |
| Guanoxabenz；Hydroxyguanabenz | C8H8Cl2N4O | 24047-25-4 | Details |
| GV-196771A | C20H15Cl2N2NaO3 | 166974-23-8 | Details |
| Product Total： Product Page： | ||||
| 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 | ||||